参考文献
[1] 中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南（2020）[J].中华妇产科杂志，2020，55（4）：227-238.
[2] Head G A，Mcgrath B P，Mihailidou A S，et al.Ambulatory blood pressure monitoring in Australia：2011 consensus position statement[J].J Hypertens，2012，30（2）：253-266.
[3] Magee L A，Pels A，Helewa M，et al.Diagnosis，evaluation，and management of the hypertensive disorders of pregnancy[J].Pregnancy Hypertens，2014，4（2）：105-145.
[4] Sibai B M.Diagnosis，prevention，and management of eclampsia[J].Obstet Gynecol，2005，105（2）：402-410.
[5] CífkováR，Johnson M R，Kahan T，et al.Peripartum management of hypertension：a position paper of the ESC Council on Hypertension and the European Society of Hypertension[J].Eur Heart J Cardiovasc Pharmacother，2020，6（6）：384-393.
[6] Pickering T G，Hall J E，Appel L J，et al.Recommendations for blood pressure measurement in humans and experimental animals：part 1：blood pressure measurement in humans：a statement for professionals from the subcommittee of professional and public education of the American heart association council on high blood pressure research[J].Hypertension，2005，45（1）：142-161.
[7] Calhoun D A，Jones D，Textor S，et al.Resistant hypertension：diagnosis，evaluation，and treatment：a scientific statement from the American Heart Association Professional Education Committee of the Council for high blood pressure Research[J].Circulation，2008，117（25）：e510-e526.
[8] Lowe S A，Bowyer L，Lust K，et al.SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014[J].Aust N Z J Obstet Gynaecol，2015，55（5）：e1-e29.
[9] Ye C，Ruan Y，Zou L，et al.The 2011 survey on hypertensive disorders of pregnancy（HDP）in China：prevalence，risk factors，complications，pregnancy and perinatal outcomes[J].PLoS One，2014，9（6）：e100180.
[10] Whelton P K，Carey R M.The 2017 clinical practice guideline for high blood pressure[J].JAMA，2017，318（21）：2073-2074.
[11] Cade T J，Gilbert S A，Polyakov A，et al.The accuracy of spot urinary protein-tocreatinine ratio in confirming proteinuria in pre-eclampsia[J].Aust N Z J Obstet Gynaecol，2012，52（2）：179-182.
[12] Tranquilli A L，Dekker G，Magee L，et al.The classification，diagnosis and management of the hypertensive disorders of pregnancy：a revised statement from the ISSHP[J].Pregnancy Hypertens，2014，4（2）：97-104.
[13] Williams P J，Broughton P F.The genetics of pre-eclampsia and other hypertensive disorders of pregnancy[J].Best Pract Res Clin Obstet Gynaecol，2011，25（4）：405-417.
[14] Brown M A，Magee L A，Kenny L C，et al.The hypertensive disorders of pregnancy：ISSHP classification，diagnosis & management recommendations for international practice[J].Pregnancy Hypertens，2018，13：291-310.
[15] Poon L C，Shennan A，Hyett J A，et al.The international federation of gynecology and obstetrics（FIGO）initiative on pre-eclampsia：a pragmatic guide for first-trimester screening and prevention[J].Int J Gynaecol Obstet，2019，145 Suppl 1（Suppl 1）：1-33.
[16] Lowe S A，Bowyer L，Lust K，et al.The SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014[J].Aust N Z J Obstet Gynaecol，2015，55（1）：11-16.
[17] Sezik M，Ozkaya O，Sezik H T，et al.Expectant management of severe preeclampsia presenting before 25 weeks of gestation[J].Med Sci Monit，2007，13（11）：CR523-CR527.